Basking Biosciences
PrivateLast Round
Seed Round
Mar 25, 2026
Total Funding Raised
$60.4M
Company Overview
Basking Biosciences operates in Healthcare & Life Sciences and is based in Columbus, Ohio. Its latest recorded funding round was a Series A round in January 2024.
Basking Biosciences is a clinical-stage biopharmaceutical company developing a novel, reversible thrombolytic therapy designed to treat acute ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basking Biosciences Comparables
Compare Basking Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmazz, Inc. | 79% | |
| Aronora, Inc. | 79% | |
| Silver Creek Pharmaceuticals | 75% |
For institutional investors. Book with your work email.
Basking Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 25, 2026 | ||||
| Series A | Jan 30, 2024 | ||||
| Seed | Dec 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Basking Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State University | Series A |
| Viva BioInnovator | Seed |
| ARCH Venture Partners | Series A |
| Rev1 Ventures | Series A, Seed |
| RTW Investments | Series A |
| Platanus Ventures | Series A |
| Insight Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 180% MoM, reaching 1.2K.
- Jun 1, 2026
Grew 27% QoQ, from 15 to 19 employees.
For institutional investors. Book with your work email.
Basking Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Basking Biosciences's valuation, stock price, and market status.
Is Basking Biosciences a public or private company?
Basking Biosciences is a private company.
What is the current stock price of Basking Biosciences?
Basking Biosciences is a private company, so its shares have no public market price. Caplight tracks Basking Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Basking Biosciences worth (valuation)?
Valuation information for Basking Biosciences is not publicly available.
Can I buy Basking Biosciences stock?
Basking Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Basking Biosciences's last funding round?
Basking Biosciences's most recent funding round was Seed Round on March 25, 2026.
Who are the main investors in Basking Biosciences?
Key investors in Basking Biosciences include Viva BioInnovator, ARCH Venture Partners, Broadview Ventures.
Will Basking Biosciences IPO soon?
No public IPO plans have been announced for Basking Biosciences.
How can I track Basking Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Basking Biosciences's shares on secondary markets.